The interaction of E-cadherin derived from tumor cells and N-cadherin derived from osteogenic cells activates the mTOR signaling pathway, which mediates the binding of these cancer cells to bone marrow stromal cells and then promotes homing of the breast cancer cells to the bone marrow (Wang et al., 2015). The gene discussed is CDH1; the disease is breast cancer.